Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 1:19 AM UTC
| NCT Number | NCT06557460 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE2 |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regenerative Patch Technologies, LLC |
| Last Updated on CT.gov | September 23, 2026 (4 weeks ago) |
As of October 22, 2026: Clinical trial NCT06557460 is currently recruiting participants. This phase2 study for macular degeneration is actively seeking new participants at 5 locations across the United States. The study is sponsored by Regenerative Patch Technologies, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06557460 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06557460 was last updated 4 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.